Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Lymphocyte Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02205333
What this trial is testing

A Phase 1b/2 Safety and Tolerability Study of MEDI6469 in Combination With Therapeutic Immune Agents or Monoclonal Antibodies

Who this might be right for
Advanced Solid TumorsAggressive B-cell Lymphomas
MedImmune LLC 48
Early research (Phase 1)Study completedNCT04765449
What this trial is testing

Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

Who this might be right for
Covid19
Thomas Jefferson University 30
Not applicableUnknownNCT06334835
What this trial is testing

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
IRCCS SYNLAB SDN 20
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Not applicableStudy completedNCT02108522
What this trial is testing

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant

Who this might be right for
Infection
AlloVir 82
Early research (Phase 1)Study completedNCT00003451
What this trial is testing

Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Active Not RecruitingNCT03016377
What this trial is testing

Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

Who this might be right for
Acute Lymphoblastic LeukemiaImmune System DiseasesImmunoproliferative Disorders
UNC Lineberger Comprehensive Cancer Center 15
Testing effectiveness (Phase 2)WithdrawnNCT03353428
What this trial is testing

Intervention of Engineered Immune Effector T Cells Against Lung Cancer

Who this might be right for
Lung CancerNSCLC
Shenzhen Geno-Immune Medical Institute
Testing effectiveness (Phase 2)Study completedNCT01386619
What this trial is testing

NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)

Who this might be right for
Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaMyelodysplastic Syndromes+3 more
University Hospital, Basel, Switzerland 15
Testing effectiveness (Phase 2)Ended earlyNCT01116232
What this trial is testing

Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more
Barbara Ann Karmanos Cancer Institute 4
Very early researchWithdrawnNCT06548620
What this trial is testing

RD06-04 in Patients With Active Autoimmune Diseases

Who this might be right for
SLESclerosisANCA Associated Vasculitis+5 more
Nanjing Bioheng Biotech Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Early research (Phase 1)Looking for participantsNCT07075185
What this trial is testing

Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma in RelapseMyeloma MultipleMultiple Myeloma Progression+11 more
Kelonia Therapeutics, Inc. 70
Early research (Phase 1)Study completedNCT00734890
What this trial is testing

Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Lung CancerLymphomaLymphoproliferative Disorder+2 more
National Institutes of Health Clinical Center (CC) 18
Early research (Phase 1)Study completedNCT00673868
What this trial is testing

Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell Transplants

Who this might be right for
Cytomegalovirus Infections
Milton S. Hershey Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT00986518
What this trial is testing

T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study

Who this might be right for
Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 5
Not applicableStudy completedNCT05733663
What this trial is testing

TCRγδ+ Cells After Gluten-free Diet: A Biomarker for Coeliac Disease?

Who this might be right for
Celiac Disease
Hospital Mutua de Terrassa 116
Testing effectiveness (Phase 2)UnknownNCT02932826
What this trial is testing

Safety Study and Therapeutic Effects of Umbilical Cord Blood Treg on Autoimmune Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Second Xiangya Hospital of Central South University 40
Testing effectiveness (Phase 2)Study completedNCT04929080
What this trial is testing

The Safety and Efficacy of Multiple-dose of JS004 in Subject With HNC

Who this might be right for
Head and Neck Squamous Cell CarcinomNasopharyngeal Carcinoma
Shanghai Junshi Bioscience Co., Ltd. 149
Next Page